Literature DB >> 15147811

Hepatic uptake of negatively charged particles in rats: possible involvement of serum proteins in recognition by scavenger receptor.

Kentaro Furumoto1, Susumu Nagayama, Ken-Ichi Ogawara, Yoshinobu Takakura, Mitsuru Hashida, Kazutaka Higaki, Toshikiro Kimura.   

Abstract

The mechanisms involved in the hepatic uptake of negatively charged carboxylated-polystyrene nanospheres with a size of 50 nm (CNS-50) were examined in rats. The liver perfusion experiments revealed that hepatic disposition of CNS-50 in the absence of serum could be partially ascribed to the direct recognition of the surface negative charge by scavenger receptors. On the other hand, the apparent negative charge of CNS-50 surface dramatically reduced in the presence of serum, because the adsorption of serum protein on their surface results in masking their intrinsic negative charge. However, hepatic disposition of CNS-50 in the presence of serum was significantly inhibited by poly inosinic acid (poly I), a typical inhibitor for scavenger receptors, and the extent of inhibition by poly I was even larger than that in the absence of serum, suggesting that the serum proteins associated on CNS-50 surface could be recognized by scavenger receptors. These results indicate that not only the intrinsic negative charge but also serum proteins associated on the surface play an important role in hepatic uptake of negatively charged particles via scavenger receptors. Coyright 2004 Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15147811     DOI: 10.1016/j.jconrel.2004.03.004

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  12 in total

1.  A peptide-based vector for efficient gene transfer in vitro and in vivo.

Authors:  Taavi Lehto; Oscar E Simonson; Imre Mäger; Kariem Ezzat; Helena Sork; Dana-Maria Copolovici; Joana R Viola; Eman M Zaghloul; Per Lundin; Pedro M D Moreno; Maarja Mäe; Nikita Oskolkov; Julia Suhorutšenko; C I Edvard Smith; Samir E L Andaloussi
Journal:  Mol Ther       Date:  2011-02-22       Impact factor: 11.454

Review 2.  Nanovehicular intracellular delivery systems.

Authors:  Ales Prokop; Jeffrey M Davidson
Journal:  J Pharm Sci       Date:  2008-09       Impact factor: 3.534

3.  Differential proteomics analysis of the surface heterogeneity of dextran iron oxide nanoparticles and the implications for their in vivo clearance.

Authors:  Dmitri Simberg; Ji-Ho Park; Priya P Karmali; Wan-Ming Zhang; Sergei Merkulov; Keith McCrae; Sangeeta N Bhatia; Michael Sailor; Erkki Ruoslahti
Journal:  Biomaterials       Date:  2009-04-26       Impact factor: 12.479

4.  In vivo retargeting of adenovirus type 5 to alphavbeta6 integrin results in reduced hepatotoxicity and improved tumor uptake following systemic delivery.

Authors:  Lynda Coughlan; Sabari Vallath; Antonio Saha; Magdalena Flak; Iain A McNeish; Georges Vassaux; John F Marshall; Ian R Hart; Gareth J Thomas
Journal:  J Virol       Date:  2009-04-15       Impact factor: 5.103

Review 5.  Recommendations for Benchmarking Preclinical Studies of Nanomedicines.

Authors:  Charlene M Dawidczyk; Luisa M Russell; Peter C Searson
Journal:  Cancer Res       Date:  2015-08-06       Impact factor: 12.701

6.  Scavenger receptor mediated endocytosis of silver nanoparticles into J774A.1 macrophages is heterogeneous.

Authors:  Hongyun Wang; Linxi Wu; Björn M Reinhard
Journal:  ACS Nano       Date:  2012-07-24       Impact factor: 15.881

7.  Polymerized Albumin Receptor of Hepatitis B Virus for Evading the Reticuloendothelial System.

Authors:  Kurumi Takagi; Masaharu Somiya; Joohee Jung; Masumi Iijima; Shun'ichi Kuroda
Journal:  Pharmaceuticals (Basel)       Date:  2021-04-25

8.  Design of a peptide-based vector, PepFect6, for efficient delivery of siRNA in cell culture and systemically in vivo.

Authors:  Samir E L Andaloussi; Taavi Lehto; Imre Mäger; Katri Rosenthal-Aizman; Iulian I Oprea; Oscar E Simonson; Helena Sork; Kariem Ezzat; Dana M Copolovici; Kaido Kurrikoff; Joana R Viola; Eman M Zaghloul; Rannar Sillard; Henrik J Johansson; Fatouma Said Hassane; Peter Guterstam; Julia Suhorutšenko; Pedro M D Moreno; Nikita Oskolkov; Jonas Hälldin; Ulf Tedebark; Andres Metspalu; Bernard Lebleu; Janne Lehtiö; C I Edvard Smith; Ulo Langel
Journal:  Nucleic Acids Res       Date:  2011-01-17       Impact factor: 16.971

9.  Tropism-modification strategies for targeted gene delivery using adenoviral vectors.

Authors:  Lynda Coughlan; Raul Alba; Alan L Parker; Angela C Bradshaw; Iain A McNeish; Stuart A Nicklin; Andrew H Baker
Journal:  Viruses       Date:  2010-10-13       Impact factor: 5.818

Review 10.  Factors Which Contribute to the Immunogenicity of Non-replicating Adenoviral Vectored Vaccines.

Authors:  Lynda Coughlan
Journal:  Front Immunol       Date:  2020-05-19       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.